STIMPOD NMS460 Nerve Stimulator— 510(k) K252712

Name: FDA 510(k) clearance K252712
Creator: U.S. Food and Drug Administration
Published: 2026-05-28

Substantially Equivalent

Algiamed Technologies USA, Inc.

FDA 510(k) clearance K252712 for STIMPOD NMS460 Nerve Stimulator, Substantially Equivalent on 2026-05-28. Applicant: Algiamed Technologies USA, Inc.. Device class: 2.

Summary

Algiamed Technologies USA's STIMPOD NMS460 Nerve Stimulator is filed under GZJ, transcutaneous nerve stimulators for pain relief.

Class II, 21 CFR 882.5890. Neurology is both the classification panel and the review panel, and the submission was a Traditional 510(k).

Algiamed filed from Lake Mary, Florida. Review took 274 calendar days (August 27, 2025 to May 28, 2026).

Clearance details

Applicant: Algiamed Technologies USA, Inc.
Product code: Product code GZJ
Device class: Class 2
Regulation: 21 CFR 882.5890
Advisory panel: Neurology
Date received: 2025-08-27
Decision date: 2026-05-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Lake Mary, FL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code GZJ

view all

K252767 — actiTENS mini2026-01-16
K252236 — CP Relief Wand Rx - TENS/NMES2025-08-15
K232441 — Unipro (K-UNIPRO-US)2024-08-30
K241228 — TENSWave2024-08-27
K233046 — Electrical Neuromuscular Stimulator, Cure Trio2024-04-19

Data sourced from openFDA. This site is unofficial and independent of the FDA.